Elevated Baseline Serum Fibrinogen: Effect on 2‐Year Major Adverse Cardiovascular Events Following Percutaneous Coronary Intervention
Journal of the American Heart Association - United Kingdom
doi 10.1161/jaha.117.006580
Full Text
Open PDFAbstract
Available in full text
Date
November 1, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)